122 related articles for article (PubMed ID: 28215647)
1. Identification of personalized dysregulated pathways in hepatocellular carcinoma.
Li H; Jiang X; Zhu S; Sui L
Pathol Res Pract; 2017 Apr; 213(4):327-332. PubMed ID: 28215647
[TBL] [Abstract][Full Text] [Related]
2. Identifying hub genes and dysregulated pathways in hepatocellular carcinoma.
Jin B; Wang W; Du G; Huang GZ; Han LT; Tang ZY; Fan DG; Li J; Zhang SZ
Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):592-601. PubMed ID: 25753876
[TBL] [Abstract][Full Text] [Related]
3. Identification and functional analysis of differentially expressed genes in poorly differentiated hepatocellular carcinoma using RNA-seq.
Huang Y; Pan J; Chen D; Zheng J; Qiu F; Li F; Wu Y; Wu W; Huang X; Qian J
Oncotarget; 2017 May; 8(22):35973-35983. PubMed ID: 28415592
[TBL] [Abstract][Full Text] [Related]
4. Transcriptome sequencing identified hub genes for hepatocellular carcinoma by weighted-gene co-expression analysis.
Pan Q; Long X; Song L; Zhao D; Li X; Li D; Li M; Zhou J; Tang X; Ren H; Ding K
Oncotarget; 2016 Jun; 7(25):38487-38499. PubMed ID: 27220887
[TBL] [Abstract][Full Text] [Related]
5. Identification of dysfunctional biological pathways and their synergistic mechanism in hepatocellular carcinoma process.
Liang J; Lv J; Liu Z
Exp Mol Pathol; 2015 Jun; 98(3):540-5. PubMed ID: 25805103
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics Analysis Reveals Distinct Molecular Characteristics of Hepatitis B-Related Hepatocellular Carcinomas from Very Early to Advanced Barcelona Clinic Liver Cancer Stages.
Kong FY; Wei X; Zhou K; Hu W; Kou YB; You HJ; Liu XM; Zheng KY; Tang RX
PLoS One; 2016; 11(7):e0158286. PubMed ID: 27454179
[TBL] [Abstract][Full Text] [Related]
7. Interaction of key pathways in sorafenib-treated hepatocellular carcinoma based on a PCR-array.
Liu Y; Wang P; Li S; Yin L; Shen H; Liu R
Int J Clin Exp Pathol; 2015; 8(3):3027-35. PubMed ID: 26045814
[TBL] [Abstract][Full Text] [Related]
8. CUL4B, NEDD4, and UGT1As involve in the TGF-β signalling in hepatocellular carcinoma.
Qu Z; Li D; Xu H; Zhang R; Li B; Sun C; Dong W; Zhang Y
Ann Hepatol; 2016; 15(4):568-76. PubMed ID: 27236156
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of gene expression profiles indicates genes in spliceosome pathway are up-regulated in hepatocellular carcinoma (HCC).
Xu W; Huang H; Yu L; Cao L
Med Oncol; 2015 Apr; 32(4):96. PubMed ID: 25731616
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of cell cycle and material metabolism related genes contributes to hepatocellular carcinoma occurrence.
Yan H; Li Z; Shen Q; Wang Q; Tian J; Jiang Q; Gao L
Pathol Res Pract; 2017 Apr; 213(4):316-321. PubMed ID: 28238542
[TBL] [Abstract][Full Text] [Related]
11. Transcript profiling identifies iqgap2(-/-) mouse as a model for advanced human hepatocellular carcinoma.
Gnatenko DV; Xu X; Zhu W; Schmidt VA
PLoS One; 2013; 8(8):e71826. PubMed ID: 23951254
[TBL] [Abstract][Full Text] [Related]
12. Aberrant gene expression profiles in hepatocellular carcinoma detected by microdissection.
Wei YM; Li YY; Zhang YC; Nie YQ
Genet Mol Res; 2013 Nov; 12(4):5527-36. PubMed ID: 24301923
[TBL] [Abstract][Full Text] [Related]
13. Identification of molecular markers for the oncogenic differentiation of hepatocellular carcinoma.
Yu GR; Kim SH; Park SH; Cui XD; Xu DY; Yu HC; Cho BH; Yeom YI; Kim SS; Kim SB; Chu IS; Kim DG
Exp Mol Med; 2007 Oct; 39(5):641-52. PubMed ID: 18059140
[TBL] [Abstract][Full Text] [Related]
14. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
[TBL] [Abstract][Full Text] [Related]
15. Gene-expression Analysis Identifies Specific Patterns of Dysregulated Molecular Pathways and Genetic Subgroups of Human Hepatocellular Carcinoma.
Hass HG; Vogel U; Scheurlen M; Jobst J
Anticancer Res; 2016 Oct; 36(10):5087-5095. PubMed ID: 27798868
[TBL] [Abstract][Full Text] [Related]
16. [Predication analysis of microarray data to determine altered gene profiles in liver carcinoma related to HBV-related cirrhosis].
Liu J; Zhang Q; Li Z; Zhang Q; Qu Y; Lu L; Xu M
Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):625-30. PubMed ID: 25243966
[TBL] [Abstract][Full Text] [Related]
17. TCGA whole-transcriptome sequencing data reveals significantly dysregulated genes and signaling pathways in hepatocellular carcinoma.
Ho DW; Kai AK; Ng IO
Front Med; 2015 Sep; 9(3):322-30. PubMed ID: 26276037
[TBL] [Abstract][Full Text] [Related]
18. Comparative transcriptome analysis reveals that the extracellular matrix receptor interaction contributes to the venous metastases of hepatocellular carcinoma.
Zhang H; Ye J; Weng X; Liu F; He L; Zhou D; Liu Y
Cancer Genet; 2015 Oct; 208(10):482-91. PubMed ID: 26271415
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated signaling hubs of liver lipid metabolism reveal hepatocellular carcinoma pathogenesis.
Lee S; Mardinoglu A; Zhang C; Lee D; Nielsen J
Nucleic Acids Res; 2016 Jul; 44(12):5529-39. PubMed ID: 27216817
[TBL] [Abstract][Full Text] [Related]
20. Identification of key genes in hepatocellular carcinoma and validation of the candidate gene, cdc25a, using gene set enrichment analysis, meta-analysis and cross-species comparison.
Lu X; Sun W; Tang Y; Zhu L; Li Y; Ou C; Yang C; Su J; Luo C; Hu Y; Cao J
Mol Med Rep; 2016 Feb; 13(2):1172-8. PubMed ID: 26647881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
